Loading stock data…
$1.77+0.02 (+1.14%)
Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. in the Healthcare sector is trading at $1.77 with a market capitalization of $6M. The stock is currently near its 52-week low of $0.97, remaining 16.5% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $5,360↑ | $2,680↓ | $3,555↑ | $2,855↓ | $7,475 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$1.50M↑ | -$1.78M↓ | -$1.46M↑ | -$1.71M↓ | -$1.68M |
| Net Income | -$1.50M↑ | -$1.79M↓ | -$1.47M↑ | -$1.71M↓ | -$1.68M |
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targe...